BILL Holdings: A Former High-Growth Stock Now Priced For RealityBy mariocazombo76@gmail.com / March 20, 2025
Ginkgo Bioworks: Declining Core Revenue And High Cash Burn Echo Amyris’ Path January 30, 2025 / DNA, Stephen Ayers / By mariocazombo76@gmail.com
Vertex: Maintaining Buy Despite Tempered Expectations For Journavx In Pain February 2, 2025 / Stephen Ayers, VRTX / By mariocazombo76@gmail.com
By
/ March 20, 2025 By
/ March 20, 2025 By
/ March 20, 2025 By
/ March 20, 2025 By
/ March 20, 2025 By
/ March 20, 2025